IP Library Granted Patent US 7,943,390
Granted Patent B2
US 7,943,390 · App. 12/426,653 · Granted May 17, 2011

Supported molecular biofluid viscosity sensors for in vitro and in vivo use

Assignees: The Curators of the University of Missouri; The Regents of the University of California; La Jolla Bioengineering Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,943,390
App. No.
12/426,653
Granted
May 17, 2011
Kind
B2
Abstract

A device and a method for measuring viscosity that includes attaching molecular rotors to a solid surface, exposing the solid surface to a fluid having a viscosity to be measured, and taking optical measurements to determine viscosity. The solid surface is preferably quartz, polystyrene or silicate glass, such as a fiber optic probe or a glass cuvette. The molecular rotors are of the type that includes an electron-donor group and electron-acceptor group that are linked by a single bond so that the groups may rotate with respect to one another, and that exhibit a fluorescence emission when rotation is hindered.

Claims (33)

1. A method for measuring viscosity comprising:

exposing a solid surface having molecular rotors attached thereto to a fluid having a viscosity to be measured; and

taking optical measurements to determine viscosity.

2. The method of claim 1 further comprising a first step of attaching molecular rotors to a solid surface.

3. The method of claim 1 wherein the molecular rotors have a structure selected from the group consisting of:

where at least one of R2, R2′ and R2″ is an electron acceptor.

4. The method of claim 3 wherein the electron acceptor is selected from the group consisting of CN, OH and a COOH.

5. The method of claim 1 wherein the molecular rotors have a structure selected from the group consisting of

where R1 and R2 are symmetric and R1 is selected from the group consisting of R1═CH 3 , an NHS ester, —[CH 2 ] n —CH3, —OH, —COOH, and esters to a carboxy group.

6. The method of claim 1 wherein the molecular rotors are selected from the group consisting of CCVJ and CCVJ-TEG.

7. The method of claim 1 wherein the solid surface is composed of one of quartz, polystyrene and silicate glass.

8. The method of claim 1 wherein the solid surface is a tip of a fiber optic probe that is coupled to a fluorometer.

9. The method of claim 1 wherein the solid surface is at least one internal wall of a glass receptacle.

10. The method of claim 8 wherein the step of exposing the solid surface comprises inserting the tip of the fiber optic probe into the fluid.

11. The method of claim 8 further comprising catheterizing the tip of the fiber optic probe for in vivo insertion.

12. The method of claim 9 wherein the step of exposing the solid surface comprises placing the fluid in the glass receptacle.

13. The method of claim 1 wherein the step of taking optical measurements comprises measuring a fluorescence emission spectrum of the molecular rotors and correlating the spectrum to a viscosity.

14. The method of claim 1 further comprising calibrating signal intensity by computing a ratio of rotor fluorescence value to a reference fluorescence value.

15. The method of claim 1 further comprising measuring an excited-state lifetime to obtain quantum yield.

16. An in vivo or in vitro method of measuring biofluid viscosity comprising:

providing a fiber optic probe having a fiber optic tip;

adhering molecular rotors to the fiber optic tip;

inserting the fiber optic tip into a predetermined environment containing a biofluid; and

measuring fluorescence though the fiber.

17. The method of claim 16 wherein the molecular rotors have a structure selected from the group consisting of

where at least one of R2, R2′ and R2″ is an electron acceptor.

18. The method of claim 16 wherein the electron acceptor is selected from the group consisting of CN, OH and a COOH.

19. The method of claim 16 wherein the molecular rotors have a structure selected from the group consisting of:

where R1 and R2 are symmetric and R1 is selected from the group consisting of R1═CH 3 , an NHS ester, —[CH 2 ] n —CH3, —OH, —COOH, and esters to a carboxy group.

20. The method of claim 16 wherein the molecular rotors are selected from the group consisting of CCVJ and CCVJ-TEG.

21. The method of claim 16 further comprising catheterizing the probe tip.

22. The method of claim 21 wherein the predetermined environment is a blood vessel.

23. The method of claim 16 further comprising coupling the fiber optic probe to a fluorometer.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: THEODORAKIS, EMMANUEL
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 026004/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: INTAGLIETTA, MARCOS
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 026004/0827 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: HAIDEKKER, MARK A.
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 026006/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: GRANT, SHEILA
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 026006/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: FRANGOS, JOHN A.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 026007/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: FRANGOS, JOHN A.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; LA JOLLA BIOENGINEERING INSTITUTE
Reel/Frame 026014/0001 →
CONFIRMATORY LICENSE Recorded Jun 10, 2010
From: UNIVERSITY OF MISSOURI COLUMBIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024513/0818 →
Continuity (3)
Division 11039076 · Jan 20, 2005
Provisional Application 60537679 · Jan 20, 2004
Related Publication 20090227880A1 · Sep 10, 2009